Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...
Objective This study examined the patterns and persistence of SARS-CoV-2 seropositivity among college students from March to ...
Objective Breastfeeding prevalence and challenges among women of systemic lupus erythematosus (SLE) and rheumatoid arthritis ...
BACKGROUND: Alternative splicing plays crucial roles in normal heart development and cardiac disease by influencing protein-coding sequences, functional domains, and molecular networks. However, a ...
The colorful exterior of Circle Thrift Too beckons from a Philadelphia street corner, promising treasures within its unassuming walls. Photo credit: Jon Kuzma Welcome to Circle Thrift in Philadelphia, ...
Introduction Safe surgical care is a cost-effective intervention for addressing a wide range of conditions, yet postoperative ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
(RTTNews) - Exact Sciences Corp. (EXAS) announced the U.S. launch of Cancerguard™, its multi-cancer early detection or MCED blood test, now available as a laboratory-developed test or LDT. Cancerguard ...
Exact Sciences drives growth through innovation in cancer detection, with strong products and a promising pipeline. Find out why EXAS stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback